Your browser doesn't support javascript.
loading
Getting patients back for routine colorectal cancer screening: Randomized controlled trial of a shared decision-making intervention.
Sepucha, Karen R; Valentine, Kathrene D; Atlas, Steven J; Chang, Yuchiao; Fairfield, Kathleen M; Ha, Jasmine; Leavitt, Lauren; Lee, Vivian; Percac-Lima, Sanja; Richter, James M; Simmons, Leigh.
Afiliação
  • Sepucha KR; Massachusetts General Hospital, Boston, Massachusetts, USA.
  • Valentine KD; Harvard Medical School, Boston, Massachusetts, USA.
  • Atlas SJ; Massachusetts General Hospital, Boston, Massachusetts, USA.
  • Chang Y; Harvard Medical School, Boston, Massachusetts, USA.
  • Fairfield KM; Massachusetts General Hospital, Boston, Massachusetts, USA.
  • Ha J; Harvard Medical School, Boston, Massachusetts, USA.
  • Leavitt L; Massachusetts General Hospital, Boston, Massachusetts, USA.
  • Lee V; Harvard Medical School, Boston, Massachusetts, USA.
  • Percac-Lima S; Maine Medical Center, Portland, Maine, USA.
  • Richter JM; Massachusetts General Hospital, Boston, Massachusetts, USA.
  • Simmons L; Massachusetts General Hospital, Boston, Massachusetts, USA.
Cancer Med ; 12(3): 3555-3566, 2023 02.
Article em En | MEDLINE | ID: mdl-36052811
ABSTRACT
Thousands of colonoscopies were canceled during the initial surge of the COVID-19 pandemic. As facilities resumed services, some patients were hesitant to reschedule. The purpose of this study was to determine whether a decision aid plus telephone coaching would increase colorectal cancer (CRC) screening and improve patient reports of shared decision making (SDM). A randomized controlled trial assigned adults aged 45-75 without prior history of CRC who had a colonoscopy canceled from March to May 2020 to intervention (n = 400) or usual care control (n = 400) arms. The intervention arm received three-page decision aid and call from decision coach from September 2020 through November 2020. Screening rates were collected at 6 months. A subset (n = 250) in each arm was surveyed 8 weeks after randomization to assess SDM (scores range 0-4, higher scores indicating more SDM), decisional conflict, and screening preference. The sample was on average, 60 years old, 53% female, 74% White, non-Hispanic, and 11% Spanish speaking. More intervention arm patients were screened within 6 months (35% intervention vs 23% control, p < 0.001). The intervention respondents reported higher SDM scores (mean difference 0.7 [0.4, 0.9], p < 0.001) and less decisional conflict than controls (-21% [-35%, -7%], p = 0.003). The majority in both arms preferred screening versus delaying (68% intervention vs. 65% control, p = 0.75). An SDM approach that offered alternatives and incorporated patients' preferences resulted in higher screening rates. Patients who are overdue for CRC screening may benefit from proactive outreach with SDM support.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Colorretais / COVID-19 Tipo de estudo: Clinical_trials / Diagnostic_studies / Prognostic_studies / Screening_studies Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Colorretais / COVID-19 Tipo de estudo: Clinical_trials / Diagnostic_studies / Prognostic_studies / Screening_studies Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2023 Tipo de documento: Article